Labcorp Holdings SG&A increased by 2.3% to $551.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.9%, from $546.00M to $551.00M. Over 4 years (FY 2021 to FY 2025), SG&A shows an upward trend with a 7.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A rising ratio of SG&A to revenue may indicate inefficiency or aggressive expansion, while a falling ratio suggests improved operating leverage.
Selling, general, and administrative expenses encompass the costs associated with the day-to-day operation of the busine...
Standard operating expense category; peers with larger global sales forces typically show higher absolute SG&A levels.
selling_general_and_administrative| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $458.70M | $519.90M | $281.90M | $464.10M | $432.40M | $453.20M | $455.50M | $457.20M | $505.80M | $525.50M | $532.90M | $508.40M | $557.80M | $568.60M | $595.20M | $546.00M | $579.30M | $552.40M | $538.60M | $551.00M |
| QoQ Change | — | +13.3% | -45.8% | +64.6% | -6.8% | +4.8% | +0.5% | +0.4% | +10.6% | +3.9% | +1.4% | -4.6% | +9.7% | +1.9% | +4.7% | -8.3% | +6.1% | -4.6% | -2.5% | +2.3% |
| YoY Change | — | — | — | — | -5.7% | -12.8% | +61.6% | -1.5% | +17.0% | +16.0% | +17.0% | +11.2% | +10.3% | +8.2% | +11.7% | +7.4% | +3.9% | -2.8% | -9.5% | +0.9% |